Eflornithine is Safer Than Melarsoprol for the Treatment of Second-Stage Trypanosoma Brucei Gambiense Human African Trypanosomiasis.
AffiliationMédecins Sans Frontières, Geneva University Hospitals, Geneva, Switzerland. firstname.lastname@example.org
MetadataShow full item record
JournalClinical Infectious Diseases
AbstractPatients with second-stage human African trypanosomiasis treated with eflornithine (n = 251) in 2003 in Kiri, southern Sudan, had an adjusted relative risk of death of 0.2 and experienced significantly fewer cutaneous and neurological adverse effects than did patients who were treated with melarsoprol in 2001 and 2002 (n = 708).
- The treatment of human African trypanosomiasis.
- Authors: Pépin J, Milord F
- Issue date: 1994
- Melarsoprol-free drug combinations for second-stage Gambian sleeping sickness: the way to go.
- Authors: Chappuis F
- Issue date: 2007 Dec 1
- [A trial treatment with eflornithine of trypanosomiasis caused by Trypanosoma brucei gambiense in the Peoples Republic of the Congo].
- Authors: Eozenou P, Jannin J, Ngampo S, Carme B, Tell GP, Schechter PJ
- Issue date: 1989 Apr-Jun
- Cost-effectiveness analysis of alternative treatments of African gambiense trypanosomiasis in Uganda.
- Authors: Politi C, Carrín G, Evans D, Kuzoe FA, Cattand PD
- Issue date: 1995 Jul-Aug
- Production of sleeping-sickness treatment.
- Authors: Pécoul B, Gastellu M
- Issue date: 1999 Sep 11